Poon Christine A 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2024/8/19 申報
- 申報編號
- 0001968202-24-000122
- 申報時間
- 2024/8/19
- 交易日
- 2024/8/15
- 申報延遲
- 4 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 8 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $1,255 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Poon Christine ACIK 0001189014 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/8/15 | Common Stock | M行使選擇權取得 | +10,838 | $413.33 | +$4,479,670.54 | 13,010 | 直接 | |
| 2024/8/15 | Common Stock | S賣出處分 | −1,012 | $1,155.72F1 | −$1,169,588.64 | 11,998 | 直接 | |
| 2024/8/15 | Common Stock | S賣出處分 | −2,368 | $1,156.30F2 | −$2,738,118.4 | 9,630 | 直接 | |
| 2024/8/15 | Common Stock | S賣出處分 | −1,560 | $1,157.33F3 | −$1,805,434.8 | 8,070 | 直接 | |
| 2024/8/15 | Common Stock | S賣出處分 | −212 | $1,158.02F4 | −$245,500.24 | 7,858 | 直接 | |
| 2024/8/15 | Common Stock | S賣出處分 | −5,352 | $1,159.56F5 | −$6,205,965.12 | 2,506 | 直接 | |
| 2024/8/15 | Common Stock | S賣出處分 | −234 | $1,160.45F6 | −$271,545.3 | 2,272 | 直接 | |
| 2024/8/15 | Common Stock | S賣出處分 | −100 | $1,161.32 | −$116,132 | 2,172 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/8/15 | Common Stock | M行使選擇權處分 | −10,838 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 1,012 shares of Company stock on August 15, 2024 at prices ranging from $1,155.38 to $1,155.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales of 2,368 shares of Company stock on August 15, 2024 at prices ranging from $1,156.04 to $1,156.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 1,560 shares of Company stock on August 15, 2024 at prices ranging from $1,157.02 to $1,157.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 212 shares of Company stock on August 15, 2024 at prices ranging from $1,158.01 to $1,158.08. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 5,352 shares of Company stock on August 15, 2024 at prices ranging from $1,159.18 to $1,159.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 234 shares of Company stock on August 15, 2024 at prices ranging from $1,160.10 to $1,160.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 15, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。